BIO-key International Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
BIO-key International, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue6.937.757.025.112.84
Cost of Revenue1.296.322.441.670.79
Gross Profit5.641.434.583.442.04
Operating Expenses
Research & Development2.512.393.252.361.40
Selling, General & Administrative7.147.869.366.035.85
Operating Expenses9.6510.2613.078.387.25
Operating Income-4.01-8.83-8.49-4.94-5.20
Other Income/Expense
Interest Income0.000.010.000.000.03
Interest Expense0.180.220.01-0.02-4.34
Other Income/Expense-0.010.38-2.280.060.16
Income
Income Before Tax-4.32-8.66-11.93-5.07-9.67
Income Tax Expense-0.02-0.13-0.020.000.00
Net Income-4.30-8.52-11.91-5.07-9.67
Net Income - Continuous Operations-4.30-8.52-11.91-5.070.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-3.67-8.01-11.37-4.67-5.04
EBIT-4.15-8.44-11.92-4.94-5.20
Depreciation & Amortization0.480.430.550.270.16
Earnings Per Share
Basic EPS-2.00-15.00-23.00-12.00-37.00
Diluted EPS-2.00-15.00-23.00-12.00-37.00
Basic Shares Outstanding2.060.560.450.430.26
Diluted Shares Outstanding2.060.560.450.430.26